Home > Boards > US Listed > Medical - Healthcare > Iovance BiotherapeutIcs (IOVA)

* * $IOVA Video Chart 04-03-2019 * *

Public Reply | Private Reply | Keep | Last ReadPost New MsgNext 10 | Previous | Next
ClayTrader Member Profile
Member Level 
Followed By 8,612
Posts 183,341
Boards Moderated 4
Alias Born 12/27/06
160x600 placeholder
Iovance Biotherapeutics Announces Four Abstracts to be Presented at the Upcoming 2019 SITC Annual Meeting GlobeNewswire Inc. - 10/2/2019 7:00:00 AM
Iovance Biotherapeutics to Present at Upcoming Conferences GlobeNewswire Inc. - 9/27/2019 4:30:00 PM
Notice of Effectiveness (effect) Edgar (US Regulatory) - 9/25/2019 6:00:54 AM
Securities Registration Statement (simplified Form) (s-3/a) Edgar (US Regulatory) - 9/17/2019 4:12:47 PM
Securities Registration Statement (simplified Form) (s-3) Edgar (US Regulatory) - 8/30/2019 5:03:11 PM
Iovance Biotherapeutics to Present at Upcoming Investor Conferences in September GlobeNewswire Inc. - 8/26/2019 4:30:00 PM
Quarterly Report (10-q) Edgar (US Regulatory) - 8/1/2019 5:03:13 PM
Current Report Filing (8-k) Edgar (US Regulatory) - 8/1/2019 4:07:54 PM
Iovance Biotherapeutics Reports Second Quarter 2019 Financial Results and Provides Corporate Update GlobeNewswire Inc. - 8/1/2019 4:01:00 PM
Iovance Biotherapeutics to Host Second Quarter 2019 Financial Results Conference Call and Webcast on Thursday, August 1, 2019... GlobeNewswire Inc. - 7/26/2019 7:00:00 AM
Statement of Changes in Beneficial Ownership (4) Edgar (US Regulatory) - 7/19/2019 5:17:30 PM
Initial Statement of Beneficial Ownership (3) Edgar (US Regulatory) - 7/19/2019 5:15:59 PM
Iovance Biotherapeutics Appoints Friedrich Graf Finckenstein, M.D., as Chief Medical Officer GlobeNewswire Inc. - 7/18/2019 8:00:00 AM
Current Report Filing (8-k) Edgar (US Regulatory) - 7/2/2019 8:01:29 AM
Iovance Biotherapeutics Provides Cervical Cancer Program Updates Following End of Phase 2 Meeting with U.S. Food and Drug Adm... GlobeNewswire Inc. - 7/2/2019 7:30:00 AM
Current Report Filing (8-k) Edgar (US Regulatory) - 6/21/2019 4:46:38 PM
Statement of Changes in Beneficial Ownership (4) Edgar (US Regulatory) - 6/11/2019 5:17:27 PM
Statement of Changes in Beneficial Ownership (4) Edgar (US Regulatory) - 6/11/2019 5:17:27 PM
Statement of Changes in Beneficial Ownership (4) Edgar (US Regulatory) - 6/11/2019 5:17:07 PM
Statement of Changes in Beneficial Ownership (4) Edgar (US Regulatory) - 6/11/2019 5:17:06 PM
Statement of Changes in Beneficial Ownership (4) Edgar (US Regulatory) - 6/11/2019 5:17:06 PM
Initial Statement of Beneficial Ownership (3) Edgar (US Regulatory) - 6/11/2019 5:16:30 PM
Current Report Filing (8-k) Edgar (US Regulatory) - 6/11/2019 8:00:58 AM
Iovance Biotherapeutics Appoints Athena Countouriotis, M.D., to Board of Directors GlobeNewswire Inc. - 6/11/2019 7:00:00 AM
Current Report Filing (8-k) Edgar (US Regulatory) - 6/3/2019 4:33:06 PM
Public Reply | Private Reply | Keep | Last ReadPost New MsgNext 10 | Previous | Next
Follow Board Follow Board Keyboard Shortcuts Report TOS Violation
X
Current Price
Change
Volume
Detailed Quote - Discussion Board
Intraday Chart
+/- to Watchlist